ENTITY
Dawnrays Pharmaceutical

Dawnrays Pharmaceutical (2348 HK)

6
Analysis
Health CareHong Kong
Dawnrays Pharmaceutical Holdings Ltd. is a pharmaceutical group primarily engaged in the development, manufacturing, and sales of cephalosporin antibiotics and various system-specific generic medicines. Its product portfolio includes pharmaceutical intermediates, bulk medicines, and finished drugs for therapeutic areas such as cardiovascular, anti-HBV, and anti-allergic systems. The company was founded in December 1995 and has its main operations in Suzhou, Jiangsu Province, China, with a corporate presence in Hong Kong.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x